Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03106766 · ClinicalTrials.gov registry record · Early Phase 1
Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.
A Early Phase 1 study, sponsored by Next Science TM.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
NCT03106766: Clinical Trial Early Phase 1 study, sponsored by Next Science TM.
NCT03106766 is a Early Phase 1 study that was terminated before completion, run by Next Science TM. The registered enrollment target is 2 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03106766, a Early Phase 1 study, was terminated before completion, sponsored by Next Science TM.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind manner.
Primary Outcome
Inflammatory acne lesions with both study acne cream products after 6 months of treatment compared to baseline. This will be measured as the mean percent change from baseline to week 24 in the inflammatory lesion count.
Interventions
- DRUG Acne cream 2X
- DRUG Acne cream 1X
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-03-27 |
| Est. Completion | 2017-08-14 |
| Phase | Early Phase 1 |
Why NCT03106766 stopped before completion
NCT03106766 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Acne cream 2X is the first listed.
NCT03106766 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03106766 about?
NCT03106766 is a clinical study titled "Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.". To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind ...
What is the current status of trial NCT03106766?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2017-03-27. Estimated completion is 2017-08-14.
What interventions are being tested in trial NCT03106766?
The interventions under investigation include: Acne cream 2X (DRUG), Acne cream 1X (DRUG).
Who is sponsoring clinical trial NCT03106766?
This trial is sponsored by Next Science TM, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03106766's enrollment target sits among peer trials
2 1973rd of 2000 higher than 16 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI